News | Endovascular Aortic Repair | April 05, 2017

New Study Confirms More Unfavorable Outcomes for Women Than Men After AAA Repair

Evidence suggests Aortic Size Index (ASI) may be a better indicator for treatment for female patients and reduces gender differences in outcomes

abdominal aortic aneurysm, AAA, gender differences, women vs. men, endovascular repair, Journal of Vascular Surgery study

April 5, 2017 — Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms of mortality and morbidity.

Aortic aneurysm rupture remains a significant cause for morbidity and mortality. With increasing awareness, as well as continued screening programs, the medical community can limit the impact of this vascular disease.

Current indications for surgical repair include aneurysm diameter greater than 5.5cm (in men), rapid growth, symptoms and rupture. Because women tend to be smaller in stature, repair at smaller diameters are often recommended. Women are less likely to develop AAA, but when they do, the aneurysm tends to grow faster and ruptures sooner than in men. Once treated, evidence suggests women have worse outcomes than men following procedures to repair AAA.

 As reported in an article in the April edition of the Journal of Vascular Surgery, researchers from Harvard’s Beth Israel Deaconess Medical Center and Massachusetts General Hospital, led by vascular surgeon Marc Schermerhorn, M.D., performed a study examining gender differences in AAA repair. 

Reviewing data from 6,611 patients undergoing AAA repair registered in the National Surgical Quality Improvement Program database, this group confirmed previous work suggesting higher morbidity and mortality in women following repair, even after adjusting for age, aortic diameter and other medical conditions.

A possible explanation for this difference proposed by the authors is that women have smaller baseline aortic diameters given their overall smaller body size. The researchers re-analyzed the data using Aortic Size Index (ASI) instead of aortic diameter. This index divides aortic diameter by body surface area. 

In doing so, Schermerhorn noted that “Adjusting for ASI reduces these (gender) differences, suggesting that ASI may be a better indicator threshold for AAA repair for female patients.”

Using ASI as a key component of indicator threshold may prevent unnecessary procedures, significantly reduce risk and increase the chances of a more favorable outcome.

For more information: www.jvascsurg.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init